09/03/2026
AOPP Live: PEMF Global Research Series, Week 3 — Why We Know
Danish university hospitals have run some of the most disciplined pulsed electromagnetic field research in the world — same device, same dose, same schedule, same measurement tool, every patient, every time. This week, Dr. Jerry Dreessen takes apart a Danish transcranial PEMF (T-PEMF) study in 58 patients with treatment-resistant depression to show exactly what protocol standardization means.
This is the most important episode for professional credibility in the series: Dr. Dreessen walks through the seven elements that let the Danish researchers make claims AOPP members can't — and four things every practitioner can adopt this month without changing a single piece of equipment.
In this episode: 0:00 Welcome Why we're covering this What the Danish researchers did Why that study can make claims and ours can't How this applies to your practice Discussion + close
Key takeaways: • Eight-week T-PEMF study, 58 adults with treatment-resistant depression, added to ongoing medication • Same device, same validated depression scale, every participant, every time • Episodes two years or shorter responded about 49%; episodes longer than two years responded about 28% • Seven elements separate evidence from observation: device, dose, duration, population, outcome instrument, comparison group, and independent oversight • Fix your protocol, adopt one outcome instrument, and define your population — starting this month
Get involved: � pemfprofessionals.com
This video discusses clinical research conducted under physician supervision. It is for educational purposes only and is not medical advice. Nothing here should be read as a claim to diagnose, treat, or cure any condition, or as clearance to operate outside your scope of practice.
